Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Understanding the Experiences of Caregivers for Children Five Years and Above Living with Sickle Cell Diseases in Kaduna, Nigeria

Halima Bello-Manga, Hayatu Musa, Bilkisu Usman, Kudirat Ahmed, Ifeoma Ijei-Enesi, Rhys Coleman, Abigail Picinich, Evelyn Lukanen, Nai Qashua, Allison A. King

Blood (2024) 144 (Supplement 1): 2245.

https://doi.org/10.1182/blood-2024-211353

Published: 2024

Journal Articles

Identifying Determinants of Sickle Cell Disease Knowledge, Awareness, and Management in St. Louis Area School Districts

Kelly M Harris, Julia Dowdy, Jasmine Miller, Timira Minor, Abigail Picinich, Catherine R Hoyt, Allison A. King

Blood (2024) 144 (Supplement 1): 396.

https://doi.org/10.1182/blood-2024-204344

Published: 2024

Journal Articles

Motixafortide (CXCR4 Inhibition) Alone and in Combination with Natalizumab (VLA-4 Inhibition) As a Novel Regimen to Mobilize Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease: A First-in-Human, Proof-of-Principle Safety and Feasibility Study

Zachary D. Crees, Michael P. Rettig, Reyka G. Jayasinghe, Stephanie Christ, Feng Gao, Hailey Sappington, Sana Saif Ur Rehman, Suzanne R. Thibodeaux, Ella Sorani, Allison A. King, John F. DiPersio

Blood (2024) 144 (Supplement 1): 145.

https://doi.org/10.1182/blood-2024-193210

Published: 2024

Journal Articles

Assessing Primary Stroke Prevention Barriers and Facilitators in Children with Sickle Cell Anemia in Puerto Rico: A Mixed Methods Study Design

Gabriela Ramirez Cuebas, Jose A. Mejias, Exa Mejías Ramos, Keishla Figueroa Colón, Mark Rodeghier, Rosa Diaz Torres, Allison A. King, Michael R. DeBaun

Blood (2024) 144 (Supplement 1): 4998.

https://doi.org/10.1182/blood-2024-200097

Published: 2024

Journal Articles

“It Was Bootstrap All the Way”: Exploring the Barriers and Facilitators to the Development of Non-Hematology Sickle Cell Disease Experts in the United States

Francis W Coyne, Deirdra R Terrell, Valerie Lang, Ashley M Jenkins, Allison A. King, Wally R Smith

Blood (2024) 144 (Supplement 1): 5202.

https://doi.org/10.1182/blood-2024-203728

Published: 2024

Journal Articles

High Concordance between Investigator-Verified Diagnosis and Manual Data Abstraction for Sickle Cell Diagnosis Type: An ASH Research Collaborative Data Hub Validation Study

Alexis Thompson, Ashima Singh, Donna S. Neuberg, Amanda M. Brandow, Allison A. King, Sophie Lanzkron, Emily A. Semmel, Sam Walters, Susan Rogers, Kathleen Hewitt, William A. Wood

Blood (2024) 144 (Supplement 1): 2313.

https://doi.org/10.1182/blood-2024-194157

Published: 2024

Journal Articles

Emergency Admissions and the Prescribing of Buprenorphine, Methadone, and Psychotropic Medications in People with Sickle Cell Disease: An Analysis of National Insurance Claims

Shiyuan Anabeth Liu, Tashalee R Brown, Lewei Allison Lin, Allison A King, Sana Saif Ur Rehman, Richard A Grucza, Kevin Y Xu

Blood (2023) 142 (Supplement 1): 3735.

https://doi.org/10.1182/blood-2023-173552

Published: 2023

Journal Articles

SCD and COVID-19 Vaccines: What Do Pediatric Patients Want to Know?

Lisa M Shook, Amy Lang, Allison A. King, Kim Smith-Whitley, Alexis A. Thompson, Christina M Barriteau, Lisa Schwartz, Cami Mosely, Eniola Oke, Fatoumatou Jallow, Lori E. Crosby

Blood (2023) 142 (Supplement 1): 7199.

https://doi.org/10.1182/blood-2023-188984

Published: 2023

Journal Articles

Utilization of Early Intervention Among Children with Sickle Cell Disease

Catherine R Hoyt, Allison A. King, Andrew Heitzer, Erin MacArthur, Ashley Wilson, Hayes Leaver

Blood (2023) 142 (Supplement 1): 3737.

https://doi.org/10.1182/blood-2023-180852

Published: 2023

Journal Articles

Association between Acute Pain Scores in Children with Sickle Cell Disease and Emergency Department Disposition and Return Visit Rates

Blood (2023) 142 (Supplement 1): 3874.

https://doi.org/10.1182/blood-2023-180273

Published: 2023

Journal Articles

Prevalence and Proportion of Transcranial Doppler Screenings in a Population Children with Sickle Cell Disease and Association with Hydroxyurea Adherence

La'Kita Knight, Paula Jean Tanabe, Audrey Blewer, James Goodrich, Allison A. King, Karin Reuter-Rice, Nancy Crego

Blood (2023) 142 (Supplement 1): 7303.

https://doi.org/10.1182/blood-2023-180093

Published: 2023

Journal Articles

Impact of an Individualized Pain Plan (IPP) for Adults with Sickle Cell Disease Experiencing a Vaso-Occlusive Episode (VOE) on Patient Satisfaction and ED Provider Confidence in Treating Pain

Rita V Masese, Lauren Siewny, Siera Gollan, Jeffrey A. Glassberg, Victor R. Gordeuk, Jane S Hankins, Cathy Melvin, Liliana Preiss, Paula Jean Tanabe, Marsha Treadwell, Allison A. King

Blood (2023) 142 (Supplement 1): 3671.

https://doi.org/10.1182/blood-2023-186906

Published: 2023

Journal Articles

Engagement with Incharge App - a Mobile Health Intervention to Improve Adherence to Hydroxyurea Among Individuals with Sickle Cell Disease

Christina M Abrams, Natalia Davila, Cathy Melvin, Sherif M. Badawy, Michael B Potter, Robert Gibson, Allison A King, Victor R. Gordeuk, Chinonyelum Nwosu, Jerlym S. Porter, Sophie Li, Jeffrey A. Glassberg, Richard Lottenberg, Lisa Klesges, Nirmish Shah, Jane S Hankins

Blood (2023) 142 (Supplement 1): 1144.

https://doi.org/10.1182/blood-2023-179272

Published: 2023

Journal Articles

Trials in Progress: Two Randomized, Double-Blind, Multicenter, Placebo-Controlled Trials Investigating the Efficacy of Voxelotor on Cerebral Blood Flow and Neurocognitive Function in Patients with Sickle Cell Disease

Melanie E. Fields, Kaitlin L Strumph, Manus J. Donahue, Mark Davis, Cesar Cisneros, Stephanie Bell, David Purdie, Emily Riehm Meier, Allison A. King

Blood (2022) 140 (Supplement 1): 2537–2538.

https://doi.org/10.1182/blood-2022-168246

Published: 2022

Journal Articles

Return Visit Rates after an Emergency Department Treat-and-Release Visit for Children with Sickle Cell Pain Episodes

Blood (2022) 140 (Supplement 1): 5418–5419.

https://doi.org/10.1182/blood-2022-166132

Published: 2022

Journal Articles

A New Phen X Collection: Sickle Cell Disease Psychosocial and Social Determinants of Health Protocols

Lori E. Crosby, Allison A. King, Jerlym S. Porter, Sherif M. Badawy, Dominique Bulgin, Steven J. Hardy, Staci D. Arnold, Desiree Williford, Marsha Treadwell, Wayne Huggins, Cataia Ives, Marian Sullivan, Carol Hamilton

Blood (2022) 140 (Supplement 1): 7898–7899.

https://doi.org/10.1182/blood-2022-167739

Published: 2022

Journal Articles

Cognitive Dysfunction Worsens with Age in Patients with Sickle Cell Disease in the Modern Treatment Era

Landon C. Power, Michael M. Binkley, Kristin P. Guilliams, Jade Beshears, Amal Hamed, Anna M Hood, Jin-Moo Lee, Andria L. Ford, Allison A. King, Melanie E. Fields

Blood (2022) 140 (Supplement 1): 5428–5430.

https://doi.org/10.1182/blood-2022-166970

Published: 2022

Journal Articles

Evaluating the Impact of a Year-Long External Mentorship Pilot Program in Classical Hematology

Zoya Qureshy, Nathan T. Connell, Alfred I Lee, Allison A. King, Martina C Murphy, Erin G Reid, Soo Park

Blood (2022) 140 (Supplement 1): 1619–1620.

https://doi.org/10.1182/blood-2022-157669

Published: 2022

Journal Articles

A Phase I Safety and Feasibility Study to Evaluate Motixafortide (CXCR4/SDF-1 Inhibition) and Natalizumab (VLA-4/VCAM-1 Inhibition) As a Novel Regimen to Mobilize CD34+ Hematopoietic Stem Cells for Gene Therapy in Sickle Cell Disease

Zachary D. Crees, Michael P. Rettig, Reyka G. Jayasinghe, Peter Ruminski, Abi Vainstein, Ella Sorani, Allison A. King, John F. DiPersio

Blood (2022) 140 (Supplement 1): 10432–10433.

https://doi.org/10.1182/blood-2022-165454

Published: 2022

Journal Articles

Optimizing Shared Decision Making about Hydroxyurea in Young Children with Sickle Cell Anemia

Blood (2022) 140 (Supplement 1): 10857–10859.

https://doi.org/10.1182/blood-2022-167914

Published: 2022

NARROW

Understanding the Experiences of Caregivers for Children Five Years and Above Living with Sickle Cell Diseases in Kaduna, Nigeria

Identifying Determinants of Sickle Cell Disease Knowledge, Awareness, and Management in St. Louis Area School Districts

Motixafortide (CXCR4 Inhibition) Alone and in Combination with Natalizumab (VLA-4 Inhibition) As a Novel Regimen to Mobilize Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease: A First-in-Human, Proof-of-Principle Safety and Feasibility Study

Assessing Primary Stroke Prevention Barriers and Facilitators in Children with Sickle Cell Anemia in Puerto Rico: A Mixed Methods Study Design

“It Was Bootstrap All the Way”: Exploring the Barriers and Facilitators to the Development of Non-Hematology Sickle Cell Disease Experts in the United States

High Concordance between Investigator-Verified Diagnosis and Manual Data Abstraction for Sickle Cell Diagnosis Type: An ASH Research Collaborative Data Hub Validation Study

Emergency Admissions and the Prescribing of Buprenorphine, Methadone, and Psychotropic Medications in People with Sickle Cell Disease: An Analysis of National Insurance Claims

SCD and COVID-19 Vaccines: What Do Pediatric Patients Want to Know?

Utilization of Early Intervention Among Children with Sickle Cell Disease

Association between Acute Pain Scores in Children with Sickle Cell Disease and Emergency Department Disposition and Return Visit Rates

Prevalence and Proportion of Transcranial Doppler Screenings in a Population Children with Sickle Cell Disease and Association with Hydroxyurea Adherence

Impact of an Individualized Pain Plan (IPP) for Adults with Sickle Cell Disease Experiencing a Vaso-Occlusive Episode (VOE) on Patient Satisfaction and ED Provider Confidence in Treating Pain

Engagement with Incharge App - a Mobile Health Intervention to Improve Adherence to Hydroxyurea Among Individuals with Sickle Cell Disease

Trials in Progress: Two Randomized, Double-Blind, Multicenter, Placebo-Controlled Trials Investigating the Efficacy of Voxelotor on Cerebral Blood Flow and Neurocognitive Function in Patients with Sickle Cell Disease

Return Visit Rates after an Emergency Department Treat-and-Release Visit for Children with Sickle Cell Pain Episodes

A New Phen X Collection: Sickle Cell Disease Psychosocial and Social Determinants of Health Protocols

Cognitive Dysfunction Worsens with Age in Patients with Sickle Cell Disease in the Modern Treatment Era

Evaluating the Impact of a Year-Long External Mentorship Pilot Program in Classical Hematology

A Phase I Safety and Feasibility Study to Evaluate Motixafortide (CXCR4/SDF-1 Inhibition) and Natalizumab (VLA-4/VCAM-1 Inhibition) As a Novel Regimen to Mobilize CD34+ Hematopoietic Stem Cells for Gene Therapy in Sickle Cell Disease

Optimizing Shared Decision Making about Hydroxyurea in Young Children with Sickle Cell Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only